Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas

Journal of Neurosurgery

Volumn 108, Issue 4, 2008, Pages 736-745

  Chang, Edward F ^a   Zada, Gabriel ^b   Kim, Sang ^c   Lamborn, Kathleen R ^a   Quinones Hinojosa, Alfredo ^d   Tyrrell, J Blake ^a   Wilson, Charles B ^a   Kunwar, Sandeep ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endocrine inactive pituitary adenoma; Nonfunctional pituitary adenoma; Radiation therapy; Recurrence; Survival; Transsphenoidal surgery

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAVERNOUS SINUS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 41849128494     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/JNS/2008/108/4/0736     Document Type: Article

References (38)

1. Arafah BM, Kailani SH, Nekl KE, Gold RS, Selman WR: Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab 79:348-354, 1994
2. Barker FG II, Klibanski A, Swearingen B: Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:4709-4719, 2003
3. Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B: Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol (Oxf) 57:713-717, 2002
4. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, et al: Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304:1343-1346, 1992
5. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, et al: The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38:571-578, 1993
6. Bradley KJ, Wass JA, Turner HE: Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol (Oxf) 58:59-64, 2003
7. Bradley KM, Adams CB, Potter CP, Wheeler DW, Anslow PJ, Burke CW: An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clin Endocrinol (Oxf) 41:655-659, 1994
8. Cappabianca P, Cavallo LM, de Divitiis E: Endoscopic endonasal transsphenoidal surgery. Neurosurgery 55:933-941, 2004
9. Ciric I, Ragin A, Baumgartner C, Pierce D: Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-227, 1997
10. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J: The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68:860-866, 1991
11. Cowper DC, Kubal JD, Maynard C, Hynes DM: A primer and comparative review of major US mortality databases. Ann Epidemiol 12:462-468, 2002
12. Erfurth EM, Bulow B, Svahn-Tapper G, Norrving B, Odh K, Mikoczy Z, et al: Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J Clin Endocrinol Metab 87:4892-4899, 2002
13. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al: The prevalence of pituitary adenomas: a systematic review. Cancer 101:613-619, 2004
14. Fisher BJ, Gaspar LE, Noone B: Radiation therapy of pituitary adenoma: delayed sequelae. Radiology 187:843-846, 1993
15. Flickinger JC, Nelson PB, Martinez AJ, Deutsch M, Taylor F: Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 63:2409-2414, 1989
16. Gittoes NJ: Radiotherapy for non-functioning pituitary tumors - when and under what circumstances? Pituitary 6:103-108, 2003
17. Gittoes NJ, Bates AS, Tse W, Bullivant B, Sheppard MC, Clayton RN, et al: Radiotherapy for non-function pituitary tumours. Clin Endocrinol (Oxf) 48:331-337, 1998
18. Greenman Y, Ouaknine G, Veshchev I, Reider G II, Segev Y, Stern N: Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 58:763-769, 2003
19. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH: Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120:817-820, 1994
20. Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors, in Kohler PO, Ross GT (eds): Diagnosis and Treatment of Pituitary Tumors. International Congress Series, Vol 303. Amsterdam: Excerpta Medica, 1973, pp 179-198
21. Kobayashi T, Mori Y, Uchiyama Y, Kida Y, Fujitani S: Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure? J Neurosurg 102 (Suppl):119-123, 2005
22. Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK, Ridgway EC: Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 43:432-439, 1998
23. Lindholm J, Nielsen EH, Bjerre P, Christiansen JS, Hagen C, Juul S, et al: Hypopituitarism and mortality in pituitary adenoma. Clin Endocrinol (Oxf) 65:51-58, 2006
24. Losa M, Valle M, Mortini P, Franzin A, da Passano CF, Cenzato M, et al: Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 100:438-444, 2004
25. McCollough WM, Marcus RB Jr, Rhoton AL Jr, Ballinger WE, Million RR: Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy. Int J Radiat Oncol Biol Phys 21:607-614, 1991
26. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M: Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90:800-804, 2005
27. Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC: Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 314:287-291, 1997
28. Park P, Chandler WF, Barkan AL, Orrego JJ, Cowan JA, Griffith KA, et al: The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 55:100-107, 2004
29. Peace KA, Orme SM, Sebastian JP, Thompson AR, Barnes S, Ellis A, et al: The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clin Endocrinol (Oxf) 46:445-450, 1997
30. Picozzi P, Losa M, Mortini P, Valle MA, Franzin A, Attuati L, et al: Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg 102 (Suppl):71-74, 2005
31. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, et al: Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47:723-730, 2000
32. Schisterman EF, Whitcomb BW: Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2:2, 2004
33. Sheehan JP, Niranjan A, Sheehan JM, Jane JA Jr, Laws ER, Kondziolka D, et al: Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:678-691, 2005
34. Snyder PJ, Fowble BF, Schatz NJ, Savino PJ, Gennarelli TA: Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 81:457-462, 1986
35. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al: Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431, 2001
36. Turner HE, Stratton IM, Byrne JV, Adams CB, Wass JA: Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clin Endocrinol (Oxf) 51:281-284, 1999
37. Wilson CG: Neurosurgical management of large and invasive pituitary tumors, in Tindall GT, Collins WF (eds): Clinical Management of Pituitary Disorders. New York: Raven Press, 1979, pp 335-342
38. Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R: Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions. J Neurosurg 98:350-358, 2003